These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30327454)

  • 21. Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain.
    García A; Ortiz de Lejarazu R; Reina J; Callejo D; Cuervo J; Morano Larragueta R
    Hum Vaccin Immunother; 2016 Sep; 12(9):2269-77. PubMed ID: 27184622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation.
    Hill EM; Petrou S; Forster H; de Lusignan S; Yonova I; Keeling MJ
    PLoS Comput Biol; 2020 Oct; 16(10):e1008278. PubMed ID: 33021983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.
    Giglio N; Gentile A; Lees L; Micone P; Armoni J; Reygrobellet C; Crépey P
    Hum Vaccin Immunother; 2012 Mar; 8(3):312-22. PubMed ID: 22330959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cost of Interventions to Increase Influenza Vaccination: A Systematic Review.
    Anderson LJ; Shekelle P; Keeler E; Uscher-Pines L; Shanman R; Morton S; Aliyev G; Nuckols TK
    Am J Prev Med; 2018 Feb; 54(2):299-315. PubMed ID: 29362167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of in- and outpatient respiratory disease and the seasonal influenza vaccination program in Armenia - 2020-2021.
    Gobin S; Sahakyan G; Kusi Appiah M; Manukyan A; Palayan K; Ebama M; Vanyan A; McCarron M; Bresee J
    Vaccine; 2024 Oct; 42 Suppl 4(Suppl 4):126007. PubMed ID: 38839517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
    Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
    Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
    Nagy L; Heikkinen T; Sackeyfio A; Pitman R
    Pharmacoeconomics; 2016 Sep; 34(9):939-51. PubMed ID: 27423657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
    Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
    BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Tsuzuki S; Baguelin M; Pebody R; van Leeuwen E
    Vaccine; 2020 Jan; 38(4):752-762. PubMed ID: 31735503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review.
    Boccalini S; Bechini A; Moscadelli A; Paoli S; Schirripa A; Bonanni P
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):911-922. PubMed ID: 33930994
    [No Abstract]   [Full Text] [Related]  

  • 33. Influenza cost and cost-effectiveness studies globally--a review.
    Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
    Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study.
    Yue M; Dickens BL; Yoong JS; I-Cheng Chen M; Teerawattananon Y; Cook AR
    Value Health; 2019 Dec; 22(12):1345-1354. PubMed ID: 31806190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
    Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic evaluations of childhood influenza vaccination: a critical review.
    Newall AT; Jit M; Beutels P
    Pharmacoeconomics; 2012 Aug; 30(8):647-60. PubMed ID: 22788257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of the cost-effectiveness of influenza immunization programs.
    Ting EEK; Sander B; Ungar WJ
    Vaccine; 2017 Apr; 35(15):1828-1843. PubMed ID: 28284681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics.
    Casanova L; Gobin N; Villani P; Verger P
    Prim Care Diabetes; 2016 Dec; 10(6):398-406. PubMed ID: 27290610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health and economic impact of the seasonal influenza vaccination programme in England.
    Baguelin M; Jit M; Miller E; Edmunds WJ
    Vaccine; 2012 May; 30(23):3459-62. PubMed ID: 22446636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly.
    Kim M; Yoo BK
    Value Health; 2015 Jul; 18(5):622-30. PubMed ID: 26297090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.